Oakworth Capital Inc. Invests $408,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Oakworth Capital Inc. acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 3,000 shares of the financial services provider’s stock, valued at approximately $408,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vontobel Holding Ltd. lifted its holdings in shares of iShares Biotechnology ETF by 9.5% in the first quarter. Vontobel Holding Ltd. now owns 5,060 shares of the financial services provider’s stock valued at $659,000 after purchasing an additional 440 shares in the last quarter. Blair William & Co. IL lifted its stake in iShares Biotechnology ETF by 9.7% in the 1st quarter. Blair William & Co. IL now owns 18,717 shares of the financial services provider’s stock valued at $2,439,000 after buying an additional 1,659 shares in the last quarter. NewEdge Advisors LLC lifted its stake in iShares Biotechnology ETF by 11.7% in the 1st quarter. NewEdge Advisors LLC now owns 13,777 shares of the financial services provider’s stock valued at $1,796,000 after buying an additional 1,445 shares in the last quarter. DCF Advisers LLC acquired a new stake in iShares Biotechnology ETF during the 1st quarter valued at $912,000. Finally, Laurel Wealth Advisors Inc. increased its position in iShares Biotechnology ETF by 22.6% during the first quarter. Laurel Wealth Advisors Inc. now owns 3,019 shares of the financial services provider’s stock worth $393,000 after buying an additional 557 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $125.89 on Thursday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16. The business has a fifty day moving average of $135.48 and a 200-day moving average of $129.55.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 annualized dividend and a yield of 0.40%. The ex-dividend date was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.